Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism

Journal of Immunology

Volumn 156, Issue 1, 1996, Pages 153-159

  Williams, Noelle Sevilir ^b   Engelhard, Victor H ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; LIGAND; MITOGENIC AGENT; PERFORIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; HOST RESISTANCE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; MIXED LYMPHOCYTE CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, CD95; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; FAS LIGAND PROTEIN; LIGANDS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; PORE FORMING CYTOTOXIC PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0030047314     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Ball, E J , and P. Stastny. 1982. Cell-mediated cytotoxicity against HLA-D-region products expressed in monocytes and B lymphocytes. IV Characterization of effector cells using monoclonal antibodies against human T-cell subsets. Immunogenetics 16 157.
2. +. Proc. Natl. Acad. Sci USA 79 2365.
3. Lukacher, A. E., L. A. Morrison, V L Braciale, B. Malissen, and T. J Braciale. 1985 Expression of specific cytolytic activity by H-2I region-restricted, influenza virus-specific T lymphocyte clones. J. Exp. Med. 162:171.
4. Golding, H., and A Singer. 1985 Specificity, phenotype, and precursor frequency of primary cytolytic T lymphocytes specific for class II major histocompatibility antigens J. Immunol. 135:1610
5. McCarthy, S. A., and A. Singer 1986. Recognition of MHC class I allodeterminants regulates the generation of MHC class II-specific CTL J. Immunol. 137. 3087.
6. Man, S., R I Lechler, J R. Batchelor, and C E M. Sharrock 1990 Individual variation in the frequency of HLA class II-specific cytotoxic T lymphocyte precursors. Eur. J. Immunol. 20:847.
7. + T cells. J Clin. Invest. 94:797
8. - T lymphocytes in culture. Nature 308.365.
9. + human cytotoxic T cell clones are restricted by class II HLA antigens. J. Immunol. 133:754
10. + cytotoxic clone to a conserved epitope on human immunodeficiency virus type 1 p24: cytotoxic activity and secretion of interleukin-2 and interleukin-6 J. Virol. 66:608
11. + human immunodeficiency virus type 1 (HIV-1) envelope-specific cytotoxic T lymphocytes derived from the peripheral blood cells of an HIV-1-infected individual AIDS Res. Hum Retroviruses 9.61
12. + surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with hepatitis B virus J Immunol 152:3074.
13. + herpes simplex virus-specific human cytotoxic T cells. J. Immunol. 143:2051
14. Kagi, D , F. Vignaux, B. Ledermann, K Burki, V Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity Science 265.528.
15. Kojima, H., N Shinohara, S. Hanaoka, Y. Someya-Shirota, Y. Takagaki, H. Ohno, T Saito, T Katayama, H. Yagita, K Okumura, Y. Shinkai, F. W. Alt. A. Matsuzawa, S. Yonehara, and H. Takayama 1994 Two distinct pathways of specific killing revealed by perform mutant cytotoxic T lymphocytes. Immunity 1:357.
16. Lowin, B , M Hahne, C. Mattmann, and J Tschopp. 1994. Cytolytic T-cell cytotoxicity is mediated through perform and Fas lytic pathways. Nature 370 650.
17. Walsh, C. M., M Matloubian, C.-C. Liu, R. Ueda, C. G. Kurahara, J. L. Christensen, M. T. F. Huang, J. D.-E Young, R. Ahmed, and W. R. Clark. 1994. Immune function in mice lacking the perform gene Proc. Natl. Acad. Sci. USA 91:10854.
18. Henkari, P A. 1994. Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity 1:343
19. Liu, C.-C , C. M. Walsh, and J. D.-E Young. 1995. Perforin: structure and function. Immunol. Today 16:194.
20. 2+ independent T cell-mediated cytotoxicity. J. Exp Med. 177:195.
21. Dennert, G., and E. R. Podack. 1983. Cytolysis by H-2 specific T killer cells: assembly of tubular complexes on target membranes. J. Exp. Med. 157:1483.
22. + lymphocytes during an acute viral infection. J Exp. Med 169:2159
23. Shiver, J. W , and P A Henkart. 1991. A noncytotoxic mast cell tumor line exhibits potent IgE-dependem cytotoxicity after transfection with the cytolysin/perform gene. Cell 64:1175.
24. Podack, E. R., H. Hengartner, and M. G. Lichtenheld. 1991 A central role of perform in cytolysis? Annu. Rev. Immunol 9:129.
25. Kagi, D , B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.
26. Strack, P., C. Martin, S. Saito, R. H. Dekruyff, and S.-T. Ju. 1990. Metabolic inhibitors distinguish cytolytic activity of CD4 and CD8 clones. Eur. J. Immunol. 20:179.
27. + T lymphocytes. J. Immunol. 146:3242
28. + T cell-mediated cytotoxicity. J. Immunol. 152:1127.
29. + cytotoxic T cells. Proc. Natl. Acad. Sci. USA 91:4185.
30. Suda, T , T. Takahashi, P. Golstein, and S Nagata. 1993 Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family Cell 75:1169.
31. Hanabuchi, S , M Koyanagi, A. Kawasaki, N Shinohara, A. Matsuzawa, Y. Nishimura, Y. Kobayashi, S. Yonehara, H. Yagita, and K. Okumura. 1994. Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA 91:4930.
32. Suda, T , T Okazaki, Y. Naito, T. Yokota, N Arai, S. Ozaki, K. Nakao, and S. Nagata. 1995. Expression of the Fas ligand in cells of T cell lineage. J. Immunol 154:3806.
33. Watanabe-Fukunaga, R., C. I Brannan, N G. Copeland, N. A. Jenkins, and S. Nagasa. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
34. Watson, M L , P. D'Eustachio, B. A Mock, A. D Steinberg, H C. Morse III, R. J. Oakley, T. A. Howard, J. M. Rochelle, and M. F Seldin 1992. A linkage map of mouse chromosome 1 using an interspecific cross segregating for the gld autoimmunity mutation. Mamm. Genome 2:158.
35. Cohen, P. L., and R. A. Eisenberg. 1991. lpr and gld. single gene models of systemic autoimmuntty and lymphoproliferative disease. Annu. Rev. Immunol. 9:243
36. Nagata, S., and T Suda. 1995 Fas and Fas ligand: lpr and gld mutations. Immunol. Today 16:39.
37. Nagata, S , and P. Golstein. 1995. The Fas death factor Science 267:1449
38. Singer, G. G., and A. K. Abbas 1994. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1:365.
39. + T cell population bearing a distinctive β chain in MRL lpr/lpr mice sugaests a role for the Fas protein in peripheral T ceil selection. Eur J. Immunol. 24 2761.
40. Vignaux, F., and P. Golstein. 1994. Fas-based lymphocyte-mediated cytotoxicity against syngeneic activated lymphocytes, a regulatory pathway? Eur J Immunol. 24.923
41. Dhein, J., H. Walczak, C. Bäumler, K.-M. Debatin, and P. H Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373.438
42. Ju, S.-T., D. J. Panka, H. Cul, R. Ettinger, M. El-Khatib, D. H. Sherr, B. Z. Stanger, and A. Marshak-Rothstein. 1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444
43. + T cells J Exp. Med. 174:875.
44. Muller, D., B. H. Koller, J. L. Whitton, K E. LaPan, K K. Brigman, and J. A. Frelinger 1992. LCMV-specific, class II-restricted cytotoxic T cells in β2-microglobulin-deficient mice. Science 255:1576.
45. + MHC class II-restricted T cells that are cytolytic in vitro and tumoricidal in vivo J Immunol 154:4613.
46. Chirgwin, J. M , A. E. Przbyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294.
47. + T cells. Curr. Opin Immunol. 7:367
48. Mariani, S M., B. Matiba, E. A. Armandola, and P. H. Krammer. 1994. The APO-1/Fas (CD95) receptor is expressed in homozygous MRL/lpr mice. Eur J. Immunol. 24:3119.
49. Matzinger, P. 1991. The JAM test, a simple assay for DNA fragmentation and cell death. J. Immunol. Meth 145:185.
50. Lynch, D. H., M L. Watson, M R. Alderson, P R. Baum, R. E Miller, T. Tough, M. Gibson, T. Davis-Smith, C. A. Smith, K. Hunter, D. Bhat, W. Din, R. G. Goodwin, and M. F. Seldin. 1994. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1:131.
51. Ramsdell, F , M. S. Seaman, R E. Miller, T. W Tough, M R Alderson, and D. H. Lynch. 1994. gld/gld mice are unable to express a functional ligand for Fas. Eur. J. Immunol. 24:928
52. Davidson, W. F , K L. Holmes, J. B. Roths, and H. C. Morse III. 1985. Immunologic abnormalities of mice bearing the gld mutation suggest a common pathway for murine nonmalignant lymphoproliferative disorders with autoimmunity. Proc. Natl. Acad. Sci. USA 82 1219.
53. Cantor, H. and E A. Boyse. 1975. Functional subclasses of T lymphocytes bearing different Ly antigens. I The generation of functionally distinct T-cell subclasses is a differentiative process independent of antigen J. Exp. Med. 141: 1376
54. Dialynas, D. P. D. B. Wilde, P Marrack, A. Pierres, K A. Wall, W. Havran, G. Otten, M. R. Loken, M. Pierres, J. Kappler, and F. W. Fitch. 1983. Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5 expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity. Immunol. Rev. 74:29.
55. Morrison, L. A., V. L. Braciale, and T. J Braciale 1988 Antigen form influences induction and frequency of influenza specific class I and class II MHC restricted cytolytic T lymphocytes. J. Immunol. 141:363
56. Schmid, D. S., and B. T. Rouse. 1992. The role of T cell immunity in control of herpes simplex virus. In Herpes Simplex Virus: Pathogenesis, Immunobiology, and Control B. T. Rouse, ed. Springer-Verlag, Berlin, p. 57
57. + T lymphocytes. Cell 77:525.
58. Hill, A , P. Jugovic, I. York, G. Russ, J. Bennink, J. Yewdell, H. Ploegh, and D. Johnson. 1995 Herpes simplex virus turns off the TAP to evade host immunity. Nature 375.411.
59. Fruh, K , K. Ahn, H. Djaballah, P. Sempé, P. M. van Endert, R. Tampé, P. A. Peterson, and Y Yang. 1995. A viral inhibitor of peptide transporters for antigen presentation. Nature 375:415.
60. + T cells in β2-microglobulin, major histocompatibility complex class I-deficient mice Eur. J Immunol 23:3115.
61. + human CTL clones induced by candidate AIDS vaccines. J. Immunol. 153.2787.
62. Braakman, E., F. T. M. Rotteveel, G van Bleek, G A van Sevemer, and C. J. Lucas. 1987. Are MHC class II-restricted cytotoxic T lymphocytes important? Immunol Today 8.265.